ReviewInternational journal of molecular sciences2022

Immunomodulatory Properties of PI3K/AKT/mTOR and MAPK/MEK/ERK Inhibition Augment Response to Immune Checkpoint Blockade in Melanoma and Triple-Negative Breast Cancer.

Zhizhu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.